Biomea Fusion

Bio-Pharma

Biomea Fusion Doses First Patient in Obesity OPAL Study

SAN CARLOS, Calif., August 13, 2026 Biomea Fusion, Inc. announced that the first participant has been dosed in a...

By cGxPwire Editor
August 14, 2026

Bio-Pharma

Biomea Fusion Reports Positive Phase II Diabetes Trial Data

BARCELONA, Spain, March 14, 2026 Clinical-stage biopharmaceutical company Biomea Fusion has reported encouraging 52-week follow-up results from its Phase...

By cGxPwire Editor
March 16, 2026

We work Hard to get you posted with latest updates

Unwrap our new Directory

Biomea Fusion

Biomea Fusion Doses First Patient in Obesity OPAL Study

Biomea Fusion Reports Positive Phase II Diabetes Trial Data